// App-Quantinova.ai

: HYDROXYCHLOROQUINE FOR THE PREVENTION OF RELAPSES IN A SERIES OF 812 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: THE HIBISCUS RETROSPECTIVE STUDY

Researchers

Presenter

  • Cristina Belizna

Principal Investigators

  • Patrick Saulnier

  • Francesca Pregnolato

  • Jaume Alijotas-Reig

  • Enrique Esteve-Valverde

  • Omar Latino

  • Sebastien Udry

  • Natasa Stanisavljevic

  • Alexander Makatsariya

  • Jamilya Khizroeva

  • Maarten Limper

  • Angela Tincani

  • Laura Andreoli

  • Francesca Regola

  • Cecilia Chighizola

  • Maria Orietta Borghi

  • Sule Apras Bilgen

  • Levent Kili

  • Arsene Mekinian

  • Valentina Canti

  • Katrien Devreese

  • Gilberto Pires Rosa

  • Laura Damian

  • Fatma Said

  • Yehuda Shoenfeld

  • Ricard Cervera

  • Pier Luigi Meroni

  • Zahir Amoura

Medical Centers

  • University Hospital of Angers, Angers, France

  • UMR CNRS6015-INSERM1083, Angers, France

  • Scientific Research Department, Internal Medicine-Rheumatology Bezhanijska Kosa, University Medical Center, Belgrade, Serbia

  • istituto auxologico italiano, Milano, Italy

  • Vall d’Hebron University Hospital, Barcelona, Spain Barcelona Spain

  • Althaia Healthcare Network of Manresa, BArcelona, Spain

  • Hospital Durand, Buenos Aires, Argentina

  • Hospital Carlos G. Durand, Buenos Aires, Buenos Aires, Argentina

  • Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia, Belgrade, Serbia

  • I.M. Sechenov First Moscow State Medical University, Moscow, Russia

  • UMC UTRECHT, UTRECHT, Netherlands

  • Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

  • University of Milan, Milan, Italy

  • Hacettepe University, Ankara, Turkey

  • AP HP Saint Antoine, Paris, France

  • Hospital San Raffaele, Milan, Italy

  • Ghent University Hospital, Ghent, Belgium, Ghent, Belgium

  • Sao Joao Hospital, Porto, Alameda, Porto, Portugal

  • Emergency Clinical County, Cluj, Romania

  • University Hospital La Rabta, Tunis, Tunisia

  • Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affliated to Sackler Faculty of Medicine, Tel-Aviv University Israel, Tel-Aviv, Israel

  • Universitat de Barcelona, Barcelona, Spain

  • HEGP, Paris, France

Locations

  • France

  • Serbia

  • Italy

  • Spain

  • Argentina

  • Russia

  • Netherlands

  • Turkey

  • Belgium

  • Portugal

  • Romania

  • Tunisia

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A